 | |
- close
- close
|
StreetInsider.com
Nov 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Albany+Molecular+Research+%28AMRI%29+Posts+Q3+Loss+of+%240.02%2C+Tops+by+2c%3B+Guides/5086690.html for the full story.
Business Wire
Nov 9
Comment
AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2009. Financial highlights for the quarter and other significant events include: Recurring royalties of $7.9 million, an increase of 39% from
Business Wire
Nov 2
Comment
AMRI (NASDAQ: AMRI) announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company (NYSE: BMY) will proceed into preclinical development. AMRI will receive a $750,000 payment from
Business Wire
Oct 30
Comment
AMRI (NASDAQ: AMRI) announced today that AMRI Director of Investor Relations Peter Jerome will present at the Oppenheimer 20th Annual Healthcare Conference in New York City on Tuesday, November 3, 2009 at 3:20 p.m. EST. An audio webcast of the
Business Wire
Oct 26
Comment
AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the market on Monday, November 9, 2009. Following the release of its results, the company will host a conference call and simultaneous webcast at
Business Wire
Sep 22
Comment
AMRI (NASDAQ:AMRI) executives were joined by Governor Christine Gregoire in dedicating the company’s new research & development facility located in Bothell, WA. The company leased 44,000 square feet at 22215 26th Avenue SE with an option on an
Business Wire
Sep 16
Comment
AMRI (NASDAQ: AMRI) announced today that AMRI Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the UBS 2009 Global Life Sciences Conference in New York City on Tuesday, September 22, 2009 at 3:30 p.m. EDT. An
The Economic Times
Sep 16
Comment
NYSE listed Dr Reddy’s Laboratories (DRL), India’s second largest company by revenue, is embroiled in a fresh patent infringement row with US based drug-discovery firm Albany Molecular Research Inc (AMRI).
Bloomberg
Sep 15
Comment
Albany Molecular Research Inc., a
medical research contractor, sued generic-drug makers Novartis
AG’s Sandoz unit and Dr. Reddy’s Laboratories Ltd., claiming
infringement of a patent used in Sanofi-Aventis’s Allegra
allergy medication, on...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
AMRI AT A GLANCE
References
| ||||||
|
|
